| scholarly article | Q13442814 |
| P2093 | author name string | Ying Chen | |
| Jian Du | |||
| Yuxian Shen | |||
| Min Li | |||
| Li Cheng | |||
| Li Yu | |||
| Qingli Luo | |||
| Ran An | |||
| Jilong Shen | |||
| Deyong Chu | |||
| He Chen | |||
| Xiucai Xu | |||
| Lijuan Wan | |||
| Lijian Chen | |||
| Yujun Shen | |||
| Aimei Zhang | |||
| Zhongru Jiang | |||
| P2860 | cites work | The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability | Q24317171 |
| COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase | Q24337774 | ||
| The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18 | Q27341809 | ||
| Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii | Q28476607 | ||
| Regulation and function of NF-kappaB transcription factors in the immune system | Q29616427 | ||
| Toxoplasmosis | Q30080013 | ||
| Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis | Q30427210 | ||
| Characterization of protein kinase A-mediated phosphorylation of ezrin in gastric parietal cell activation | Q31148511 | ||
| ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii | Q33274196 | ||
| A single polymorphic amino acid on Toxoplasma gondii kinase ROP16 determines the direct and strain-specific activation of Stat3. | Q33591077 | ||
| NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS. | Q33814730 | ||
| Alternative versus classical activation of macrophages. | Q33868142 | ||
| Toxoplasma gondii rhoptry kinase ROP16 activates STAT3 and STAT6 resulting in cytokine inhibition and arginase-1-dependent growth control | Q34023014 | ||
| Modulation of innate immunity by Toxoplasma gondii virulence effectors | Q34033981 | ||
| Toxoplasma rhoptry protein 16 (ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. | Q34121309 | ||
| Interactions between the ROP18 kinase and host cell proteins that aid in the parasitism of Toxoplasma gondii | Q34172319 | ||
| The rhoptry proteins ROP18 and ROP5 mediate Toxoplasma gondii evasion of the murine, but not the human, interferon-gamma response. | Q34325516 | ||
| Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. | Q34501481 | ||
| A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii | Q34591236 | ||
| Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination | Q34959023 | ||
| Toxoplasma polymorphic effectors determine macrophage polarization and intestinal inflammation. | Q35090382 | ||
| ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18. | Q35102296 | ||
| COMMD proteins and the control of the NF kappa B pathway | Q36760008 | ||
| Polymorphic secreted kinases are key virulence factors in toxoplasmosis | Q37105671 | ||
| Toxoplasma gondii prevents chromatin remodeling initiated by TLR-triggered macrophage activation | Q37117107 | ||
| Toxoplasma gondii inhibits apoptosis in infected cells by caspase inactivation and NF-kappaB activation | Q37205977 | ||
| Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway | Q37723806 | ||
| 14-3-3zeta cooperates with phosphorylated Plk1 and is required for correct cytokinesis | Q37971772 | ||
| NF-κB: where did it come from and why? | Q37995678 | ||
| NF-κB and the link between inflammation and cancer | Q37995696 | ||
| Advances in understanding immunity to Toxoplasma gondii | Q39980910 | ||
| Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-kappa B. | Q40787838 | ||
| Macrophages as a battleground for toxoplasma pathogenesis | Q42766938 | ||
| Inhibition of caspase activation and a requirement for NF-kappaB function in the Toxoplasma gondii-mediated blockade of host apoptosis | Q42796145 | ||
| Activation of NF-kappaB by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated IkappaB to the parasitophorous vacuole membrane | Q42796162 | ||
| Production of IL-12 by macrophages infected with Toxoplasma gondii depends on the parasite genotype | Q47991756 | ||
| Congenital toxoplasmosis: continued parasite proliferation in the fetal brain despite maternal immunological control in other tissues | Q48332630 | ||
| Toxoplasma gondii interferes with lipopolysaccharide-induced mitogen-activated protein kinase activation by mechanisms distinct from endotoxin tolerance. | Q51024816 | ||
| Initiation and termination of NF-kappaB signaling by the intracellular protozoan parasite Toxoplasma gondii. | Q54201258 | ||
| Suppression of NF‐κB Activation by Infection withToxoplasma gondii | Q64140406 | ||
| Detection of a novel parasite kinase activity at the Toxoplasma gondii parasitophorous vacuole membrane capable of phosphorylating host IkappaBalpha | Q81338152 | ||
| Host and parasite-derived IKK activities direct distinct temporal phases of NF-kappaB activation and target gene expression following Toxoplasma gondii infection | Q81598989 | ||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| Toxoplasma gondii | Q131003 | ||
| P1104 | number of pages | 15 | |
| P304 | page(s) | 12578-12592 | |
| P577 | publication date | 2014-03-19 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Toxoplasma gondii virulence factor ROP18 inhibits the host NF-κB pathway by promoting p65 degradation | |
| P478 | volume | 289 |
| Q93086633 | A CRISPR platform for targeted in vivo screens identifies Toxoplasma gondii virulence factors in mice |
| Q38721370 | A Human Proteome Array Approach to Identifying Key Host Proteins Targeted by Toxoplasma Kinase ROP18. |
| Q47095280 | A mechanistic study of Toxoplasma gondii ROP18 inhibiting differentiation of C17.2 neural stem cells |
| Q40369803 | Characterization of the Neospora caninum NcROP40 and NcROP2Fam-1 rhoptry proteins during the tachyzoite lytic cycle. |
| Q54108260 | Encephalitis is mediated by ROP18 of Toxoplasma gondii, a severe pathogen in AIDS patients. |
| Q49829407 | Genome-Wide Bimolecular Fluorescence Complementation-Based Proteomic Analysis of Toxoplasma gondii ROP18's Human Interactome Shows Its Key Role in Regulation of Cell Immunity and Apoptosis |
| Q47100441 | Host Cell Vimentin Restrains Toxoplasma gondii Invasion and Phosphorylation of Vimentin is Partially Regulated by Interaction with TgROP18. |
| Q41684078 | Host-Toxoplasma gondii Coadaptation Leads to Fine Tuning of the Immune Response |
| Q38533835 | Host-parasite interactions: an intimate epigenetic relationship |
| Q33610342 | Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice |
| Q92190843 | Influence of Two Major Toxoplasma Gondii Virulence Factors (ROP16 and ROP18) on the Immune Response of Peripheral Blood Mononuclear Cells to Human Toxoplasmosis Infection |
| Q51148229 | Integrative Approaches to Understand the Mastery in Manipulation of Host Cytokine Networks by Protozoan Parasites with Emphasis on Plasmodium and Leishmania Species. |
| Q64075094 | Modulates the Host Cell Responses: An Overview of Apoptosis Pathways |
| Q33847259 | Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection |
| Q35954233 | Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells |
| Q47095242 | Plasmodium falciparum PfEMP1 Modulates Monocyte/Macrophage Transcription Factor Activation and Cytokine and Chemokine Responses |
| Q47624929 | Post-translational modifications as key regulators of apicomplexan biology: insights from proteome-wide studies. |
| Q59799911 | Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18 |
| Q22255525 | Proteome-wide lysine acetylation in cortical astrocytes and alterations that occur during infection with brain parasite Toxoplasma gondii |
| Q90290829 | Rhoptry and Dense Granule Secreted Effectors Regulate CD8+ T Cell Recognition of Toxoplasma gondii Infected Host Cells |
| Q37119146 | Secretion of Rhoptry and Dense Granule Effector Proteins by Nonreplicating Toxoplasma gondii Uracil Auxotrophs Controls the Development of Antitumor Immunity |
| Q98166347 | Strain-specific disruption of interferon-stimulated N-myc and STAT interactor (NMI) function by Toxoplasma gondii type I ROP18 in human cells |
| Q64085047 | Strategies Developed by to Survive in the Host |
| Q36201858 | T. gondii rhoptry protein ROP18 induces apoptosis of neural cells via endoplasmic reticulum stress pathway |
| Q37123452 | The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection. |
| Q36804346 | The gene expression level of IFN-γR1 and IFN-γR2 in a murine model treated with Toxoplasma gondii and its products |
| Q40047888 | Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer. |
| Q98735549 | Toxoplasma gondii Dense Granule Proteins 7, 14, and 15 Are Involved in Modification and Control of the Immune Response Mediated via NF-κB Pathway |
| Q66905238 | Toxoplasma gondii ROP17 inhibits the innate immune response of HEK293T cells to promote its survival |
| Q64930990 | Toxoplasma gondii ROP18 inhibits human glioblastoma cell apoptosis through a mitochondrial pathway by targeting host cell P2X1. |
| Q40934842 | Transcriptomic analysis of global changes in cytokine expression in mouse spleens following acute Toxoplasma gondii infection |
| Q90053650 | iTRAQ-Based Global Phosphoproteomics Reveals Novel Molecular Differences Between Toxoplasma gondii Strains of Different Genotypes |
Search more.